Oncolytic Virus Immunotherapy and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Oncolytic Virus Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncolytic Virus Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncolytic Virus Immunotherapy Overall Market Size
2.1 Global Oncolytic Virus Immunotherapy Market Size: 2022 VS 2035
2.2 Global Oncolytic Virus Immunotherapy Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncolytic Virus Immunotherapy Players in Global Market
3.2 Top Global Oncolytic Virus Immunotherapy Companies Ranked by Revenue
3.3 Global Oncolytic Virus Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 Oncolytic Virus Immunotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oncolytic Virus Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncolytic Virus Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 Oncolytic Virus Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncolytic Virus Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oncolytic Virus Immunotherapy Market Size Markets, 2022 & 2035
4.1.2 Engineering Oncolytic Viruses
4.1.3 Wild-Type Oncolytic Viruses
4.2 By Type - Global Oncolytic Virus Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global Oncolytic Virus Immunotherapy Revenue, 2018-2023
4.2.2 By Type - Global Oncolytic Virus Immunotherapy Revenue, 2024-2035
4.2.3 By Type - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncolytic Virus Immunotherapy Market Size, 2022 & 2035
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Ambulatory Surgical Centers
5.2 By Application - Global Oncolytic Virus Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global Oncolytic Virus Immunotherapy Revenue, 2018-2023
5.2.2 By Application - Global Oncolytic Virus Immunotherapy Revenue, 2024-2035
5.2.3 By Application - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Oncolytic Virus Immunotherapy Market Size, 2022 & 2035
6.2 By Region - Global Oncolytic Virus Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global Oncolytic Virus Immunotherapy Revenue, 2018-2023
6.2.2 By Region - Global Oncolytic Virus Immunotherapy Revenue, 2024-2035
6.2.3 By Region - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Oncolytic Virus Immunotherapy Revenue, 2018-2035
6.3.2 US Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.3.3 Canada Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.3.4 Mexico Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Oncolytic Virus Immunotherapy Revenue, 2018-2035
6.4.2 Germany Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.4.3 France Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.4.4 U.K. Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.4.5 Italy Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.4.6 Russia Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.4.7 Nordic Countries Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.4.8 Benelux Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Oncolytic Virus Immunotherapy Revenue, 2018-2035
6.5.2 China Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.5.3 Japan Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.5.4 South Korea Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.5.5 Southeast Asia Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.5.6 India Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Oncolytic Virus Immunotherapy Revenue, 2018-2035
6.6.2 Brazil Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.6.3 Argentina Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncolytic Virus Immunotherapy Revenue, 2018-2035
6.7.2 Turkey Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.7.3 Israel Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.7.4 Saudi Arabia Oncolytic Virus Immunotherapy Market Size, 2018-2035
6.7.5 UAE Oncolytic Virus Immunotherapy Market Size, 2018-2035
7 Oncolytic Virus Immunotherapy Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Oncolytic Virus Immunotherapy Major Product Offerings
7.1.4 Merck Oncolytic Virus Immunotherapy Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Oncolytic Virus Immunotherapy Major Product Offerings
7.2.4 Amgen Oncolytic Virus Immunotherapy Revenue in Global Market (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 TILT Biotherapeutics
7.3.1 TILT Biotherapeutics Company Summary
7.3.2 TILT Biotherapeutics Business Overview
7.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Major Product Offerings
7.3.4 TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue in Global Market (2018-2023)
7.3.5 TILT Biotherapeutics Key News & Latest Developments
7.4 Oncorus
7.4.1 Oncorus Company Summary
7.4.2 Oncorus Business Overview
7.4.3 Oncorus Oncolytic Virus Immunotherapy Major Product Offerings
7.4.4 Oncorus Oncolytic Virus Immunotherapy Revenue in Global Market (2018-2023)
7.4.5 Oncorus Key News & Latest Developments
7.5 Sorrento Therapeutics
7.5.1 Sorrento Therapeutics Company Summary
7.5.2 Sorrento Therapeutics Business Overview
7.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Major Product Offerings
7.5.4 Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue in Global Market (2018-2023)
7.5.5 Sorrento Therapeutics Key News & Latest Developments
7.6 Shanghai Sunway Biotech
7.6.1 Shanghai Sunway Biotech Company Summary
7.6.2 Shanghai Sunway Biotech Business Overview
7.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Major Product Offerings
7.6.4 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue in Global Market (2018-2023)
7.6.5 Shanghai Sunway Biotech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Oncolytic Virus Immunotherapy Market Opportunities & Trends in Global Market
Table 2. Oncolytic Virus Immunotherapy Market Drivers in Global Market
Table 3. Oncolytic Virus Immunotherapy Market Restraints in Global Market
Table 4. Key Players of Oncolytic Virus Immunotherapy in Global Market
Table 5. Top Oncolytic Virus Immunotherapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Oncolytic Virus Immunotherapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Oncolytic Virus Immunotherapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Oncolytic Virus Immunotherapy Product Type
Table 9. List of Global Tier 1 Oncolytic Virus Immunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncolytic Virus Immunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Oncolytic Virus Immunotherapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Oncolytic Virus Immunotherapy Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Oncolytic Virus Immunotherapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Oncolytic Virus Immunotherapy Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Oncolytic Virus Immunotherapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Oncolytic Virus Immunotherapy Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2024-2035
Table 30. Merck Company Summary
Table 31. Merck Oncolytic Virus Immunotherapy Product Offerings
Table 32. Merck Oncolytic Virus Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Key News & Latest Developments
Table 34. Amgen Company Summary
Table 35. Amgen Oncolytic Virus Immunotherapy Product Offerings
Table 36. Amgen Oncolytic Virus Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 37. Amgen Key News & Latest Developments
Table 38. TILT Biotherapeutics Company Summary
Table 39. TILT Biotherapeutics Oncolytic Virus Immunotherapy Product Offerings
Table 40. TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 41. TILT Biotherapeutics Key News & Latest Developments
Table 42. Oncorus Company Summary
Table 43. Oncorus Oncolytic Virus Immunotherapy Product Offerings
Table 44. Oncorus Oncolytic Virus Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 45. Oncorus Key News & Latest Developments
Table 46. Sorrento Therapeutics Company Summary
Table 47. Sorrento Therapeutics Oncolytic Virus Immunotherapy Product Offerings
Table 48. Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 49. Sorrento Therapeutics Key News & Latest Developments
Table 50. Shanghai Sunway Biotech Company Summary
Table 51. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Product Offerings
Table 52. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 53. Shanghai Sunway Biotech Key News & Latest Developments
List of Figures
Figure 1. Oncolytic Virus Immunotherapy Segment by Type in 2022
Figure 2. Oncolytic Virus Immunotherapy Segment by Application in 2022
Figure 3. Global Oncolytic Virus Immunotherapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oncolytic Virus Immunotherapy Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Oncolytic Virus Immunotherapy Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncolytic Virus Immunotherapy Revenue in 2022
Figure 8. By Type - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 9. By Application - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 10. By Type - Global Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 12. By Application - Global Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 14. By Region - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 15. By Country - North America Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 16. US Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 20. Germany Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 21. France Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 28. China Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 32. India Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 34. Brazil Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Oncolytic Virus Immunotherapy Revenue Market Share, 2018-2035
Figure 37. Turkey Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2018-2035
Figure 41. Merck Oncolytic Virus Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Amgen Oncolytic Virus Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Oncorus Oncolytic Virus Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
